Hong Kong stock surged again, with Tenscent Bao-Yao-B (02137.HK) rising over 8%. In the near future, it will grant exclusive license for new drug BRII-693 in Greater China to Health Element Group.

According to the Wisdom Finance and Economics app, Tengsheng Boyao-B (02137.HK) has increased by over 8% again. As of the time of writing, it has increased by 8.21% to 2.11 Hong Kong dollars, with a turnover of 11.67 million Hong Kong dollars.